In this review:
Drivers of long-term remission
Antibody presence linked to bone pathology in RA
Update on non anti-TNF biologics
New classifications for vasculitides
Stem cells: a useful therapeutic target in OA?
Responses to biologics compared in RA
Clinical scleroderma
Please login below to download this issue (PDF)